Archimedes Pharma Overview
- Founded
-
2005
- Status
-
Acquired/Merged
- Employees
-
22
- Latest Deal Type
-
M&A
- Financing Rounds
-
4
- Investments
-
2
Archimedes Pharma General Information
Description
Producer of pharmaceuticals for the European markets. The company was created to form a pan-European specialty pharmaceutical company through a roll-up of European pharmaceutical businesses and offers products that treat high-grade glioma, cancer pain, alcohol misuse, thromboprophylaxis and moderate to severe pain.
Contact Information
Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Pharmaceuticals
Acquirer
Primary Office
- 250 South Oak Way Green Park
- Reading RG2 6UG
- England, United Kingdom
Archimedes Pharma Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Archimedes Pharma Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Archimedes Pharma Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Archimedes Pharma Investments (2)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 0000000000 00 | 06-Nov-2006 | 0000000000 | Pharmaceuticals | 0000000 0 | |
| West Pharmaceutical Services (Drug Delivery Business) | 08-Feb-2005 | Buyout/LBO | 000.00 | Drug Delivery | 0000000 0 |